Danny Fernando Silva Cevallos¹*, Juan Salazar Flores², Lorena Jacqueline Aragón Quijano³, Edison Moreno Rivas⁴, Jessica Paola Guallpa², Diana Salazar Flores⁵, Raul Naranjo Alulema² and Fernando Silva Michalón⁶

¹ISA Specialist in Internal Medicine/Clinica Guayaquil Emergencias, University of Guayaquil, Ecuador

*Corresponding Author: Danny Fernando Silva Cevallos, ISA Specialist in Internal Medicine/Clinica Guayaquil Emergencias, University of Guayaquil, Ecuador.

Received: June 23, 2022; Published: July 29, 2022

Abstract

Hashitoxicosis in a pathological entity considered as the second cause in frequency after Graves Basedow's thyroiditis, characterized by a state of hypermetabolism due to the increase in thyroid hormones due to an inflammatory reaction to the thyroid gland.

We present the case of a 34-year-old female patient with cardiac comorbidities who presented to the terations in the tests of hormonal function compatible with hiperthyroidism, however, the determination of antibodies allowed to establish the diagnosis of Hashimoto's Disease.

This clinical case report is made due to the limited information on the knowledge of the mixed thyroid autoimmune effect in the same patient.

With the description of the case it is intended to open a range of more research of this type and thereby improve the quality of life of patients who have this pathology.

Keywords: Hashimoto; Autoimmune; Hormonal; Hiperthyroidism; Hashitoxicosis

References

1. Marín G ME., et al. “Hashitoxicosis: a case report”. Revista Médica de Risaralda 1 (2016): 61-63.
2. Shahbaz A., et al. “Prolonged Duration of Hashitoxicosis in a Patient with Hashimoto’s Thyroiditis: A Case Report and Review of Literature”. Cureus6 (2018): 14-16.
3. Lee HJ., et al. “Immunogenetics of autoimmune thyroid diseases: A comprehensive review”. Journal of Autoimmunity 64 (2015): 82-90.
4. Caturegli P., et al. “Hashimoto thyroiditis: Clinical and diagnostic criteria”. Autoimmunity Review 4-5 (2014): 391-397.
5. Escobar M., et al. “Prevalence of antiperoxidase and antithyroglobulin antibodies in young people with subclinical and clinical hypothyroidism”. Medicina and Laboratorio (2011): 7-8.
6. Unnikrishnan A. “Hashitoxicosis: A clinical perspective”. Thyroid Research and Practice 4 (2013): 5.
7. Vita R., et al. “Stress-induced hashitoxicosis: case report and relative HLA serotype and genotype”. Revista da Associacao Medica Brasileira 6 (2019): 830-833.
8. Satoh M., et al. “Effect of treatment with epoprostenol and endothelin receptor antagonists on the development of thyrotoxicosis in patients with pulmonary arterial hypertension”. Endocrine Journal 64 (2017): 1173-1180.
9. Dunne C and De Luca F. “Long-Term Follow-Up of a Child with Autoimmune Thyroiditis and Recurrent Hyperthyroidism in the Absence of TSH Receptor Antibodies”. Case Reports in Endocrinology (2014): 1-4.

Citation

Citation: Danny Fernando Silva Cevallos., et al. “Hashitoxicosis, About a Clinical Case". Acta Scientific Gastrointestinal Disorders 5.8 (2022): 48-51.

Copyright

Copyright: © 2022 Danny Fernando Silva Cevallos., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.